Latest Reports

The “2024 Premium Cataract Surgery Market Report” is designed to provide insights into the most important premium cataract surgery (PCS) markets in the world. We’ve selected and profiled 13 countries that collectively account for 84 percent of global PCS manufacturer revenue and provided a deep dive into each of these markets. Ranked by 2024 PCS manufacturer revenue, they are: the United States, China, Japan, France, Germany, Brazil, Canada, India, Spain, South Korea, Australia, the UK, and Italy.  

For each of these countries, the report focuses on specific characteristics considered vital to the understanding of the opportunities for companies planning to market premium cataract surgery devices or looking to assess the value of each market. 

The “2024 Retinal Pharmaceuticals Market Report: GA and Other Nonexudative Diseases” analyzes the market for complement inhibitors, gene therapies, antioxidants, sustained-release devices, and other treatments for geographic atrophy, dry AMD, and additional nonexudative retinal diseases. The report discusses important trends, analyzes key factors for future market success, examines disease prevalence, reviews patient economics and reimbursement, and forecasts growth over the next five years. Product demand is forecast in units and dollars, and market shares are analyzed by product category. Additionally, 19 competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

The “2024 Ophthalmic OR Microscopes Market Report” is a specialized supplement, expanding on the OR microscope section of Market Scope’s “2024 Ophthalmic Diagnostic Equipment Market Report.” The report is a leading industry source for information on all aspects of the global ophthalmic OR microscopes market.  

The report covers background information on the devices and groups market estimates into three categories: basic microscope models, standard microscope models, and advanced microscope models. Estimates include unit sales, installed equipment base, average prices, and information about the manufacturers that participate in the market.

The “2024 Single-Use Ophthalmic Surgical Products Market Report” examines global and regional markets for single-use ophthalmic surgical products. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.  The report reviews cataract surgery, the dominant procedure in this market, as well as cataract surgery providers worldwide.  

Market segments profiled include viscoelastics, knives, disposable instruments, balanced salt solutions, procedure packs, drapes, sutures, fluid management devices, eye shields, ocular dyes, capsular tension rings, and cautery pencils. 

Additionally, 25 companies are profiled, with discussion of their products, strategic market position, background, and outlook. 

The “2024 Retinal Pharmaceuticals Market Report: Wet AMD and Other Exudative Diseases” analyzes the market for anti-VEGFs and other drugs for the treatment of exudative retinal diseases. The report discusses important trends, analyzes key factors for future market success, examines the market’s evolution, and forecasts growth over the next five years. Product demand is forecast in units and dollars, and market shares are analyzed by product category. Additionally, 40 competitors are profiled, with discussion of their products, strategic market position, background, and outlook. 

The “2024 Glaucoma Surgical Device Market Report” offers a comprehensive analysis of the current global market for glaucoma devices, as well as a discussion of important trends, an examination of upcoming products that will impact the market, and a review of other key factors shaping future success.  

The report analyzes the prevalence of glaucoma worldwide and discusses the ophthalmologists who treat glaucoma. It also examines the role of surgical intervention, the market dynamics for currently commercialized products, and the pipeline of investigational devices that may offer improved outcomes.  

Product demand is forecast in units and dollars, and market shares are analyzed by product category. Twenty-two market competitors are profiled, with discussion of their products, strategic market position, background, and outlook. 

Market Scope’s “2024 Ophthalmic Diagnostic Equipment Market Report” provides in-depth coverage of ophthalmic diagnostic equipment used during ophthalmic exams and procedures, analyzing over 800 devices from 115 manufacturers. This comprehensive report examines the factors shaping the market and identifies trends.  

The report analyzes markets for diagnostic technologies that include corneal topographers, various microscopes, anterior eye scanners, biometers, tonometers, fundus cameras, perimeters, refractors, slit lamps, and many more devices. For each device category, the report discusses pricing, competitor market share, the installed equipment base, and emerging technologies. 

The “2024 Cataract Surgical Equipment Market Report” provides in-depth analysis of the global cataract surgical equipment market, examining the market’s size and growth, as well as identifying important developments that may shape its future. Product coverage includes ultrasonic phaco machines, packs, and accessories; femtosecond laser-assisted cataract surgery systems; and photodisruptor lasers. 

The analysis focuses on the 2024 market and forecasts growth and evolution through 2029. Product demand is forecast in units and dollars, and market shares are analyzed by product category. Additionally, 21 competitors are profiled, with discussion of their products, strategic market position, background, and outlook. 

The “2024 Glaucoma Pharmaceuticals Market Report” analyzes the global and regional markets for glaucoma pharmaceuticals, identifying important trends and key factors for future success. The report provides forecasts through 2029 for branded prostaglandins, generic prostaglandins, beta blockers, carbonic anhydrase inhibitors, alpha agonists, fixed combo drugs, NO-donating compounds, and Rho-kinase inhibitors. The report also extensively discusses pipeline products, covering over 30 drug candidates that are currently under development. Additionally, 26 glaucoma pharmaceutical companies are profiled, with discussion of their products, strategic market position, background, and outlook.

The “2024 United States Cataract Atlas” provides a geographic analysis of the conventional and premium cataract surgery opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.